Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-25 00:44 | 2024-09-23 | N/A | N/A | Abu Dhabi Investment Authority | 10% owner | Other | BUY | $1,844.16 | 6,778 | $12,499,999 | 63,363 | +12.0% |
| 2024-09-25 00:19 | 2024-09-23 | N/A | N/A | Abu Dhabi Investment Authority | 10% owner | Other | BUY | $14.88 | 1,344,203 | $19,999,987 | 12,320,835 | +12.2% |
| 2024-09-24 23:31 | 2024-09-20 | AB | AllianceBernstein Holding L.P. | Equitable Holdings, Inc. | Other | Investment Advice | BUY | $34.18 | 500,000 | $17,091,700 | 3,066,838 | +19.5% |
| 2024-09-25 01:38 | 2024-09-20 | PBF | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Petroleum Refining | BUY | $31.83 | 515,000 | $16,391,472 | 23,217,398 | +2.3% |
| 2024-09-24 23:05 | 2024-05-01 | N/A | N/A | COHEN JONATHAN H | Director, Officer - Chief Executive Officer | Other | BUY | $27.90 | 197,129 | $5,500,045 | 237,129 | +492.8% |
| 2024-09-24 23:03 | 2024-05-01 | N/A | N/A | ROSENTHAL SAUL B | Director, Officer - President | Other | BUY | $27.90 | 197,129 | $5,500,045 | 237,129 | +492.8% |
| 2024-09-24 23:01 | 2024-09-20 | CAPR | CAPRICOR THERAPEUTICS, INC. | Nippon Shinyaku Co Ltd | 10% owner | Pharmaceutical Preparations | BUY | $5.36 | 2,798,507 | $14,999,998 | 7,090,351 | +65.2% |
| 2024-09-24 00:54 | 2024-09-19 | SOC | Sable Offshore Corp. | Pilgrim Global ICAV | 10% owner | Crude Petroleum & Natural Gas | BUY | $20.00 | 750,000 | $15,000,000 | 8,791,001 | +9.3% |
| 2024-09-23 23:28 | 2024-09-19 | CRMT | AMERICAS CARMART INC | Peterson Adam K | 10% owner | Retail-Auto Dealers & Gasoline Stations | BUY | $43.00 | 813,953 | $34,999,979 | 1,582,363 | +105.9% |
| 2024-09-23 17:57 | 2024-09-19 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.59 | 228,255 | $1,732,455 | 55,567,425 | +0.4% |
| 2024-09-23 23:27 | 2024-09-20 | N/A | N/A | Regan Kenneth P | Officer, 10% owner, Other - CHIEF EXECUTIVE OFFICER | Other | BUY | $23.00 | 110,000 | $2,530,000 | 131,215 | +518.5% |
| 2024-09-24 00:19 | 2024-09-20 | CDXS | CODEXIS, INC. | Opaleye Management Inc. | 10% owner | Industrial Organic Chemicals | BUY | $3.01 | 1,100,000 | $3,308,030 | 8,435,000 | +15.0% |
| 2024-09-23 13:30 | 2024-09-20 | HPK | HighPeak Energy, Inc. | HIGHTOWER JACK | Director, Officer, 10% owner - Chief Executive Officer | Drilling Oil & Gas Wells | BUY | $15.54 | 100,000 | $1,554,000 | 4,959,255 | +2.1% |
| 2024-09-21 03:43 | 2024-09-19 | CRMT | AMERICAS CARMART INC | Buba Jonathan Z | Director | Retail-Auto Dealers & Gasoline Stations | BUY | $43.00 | 232,558 | $9,999,994 | 544,686 | +74.5% |
| 2024-09-20 21:43 | 2024-09-12 | CNTM | ConnectM Technology Solutions, Inc. | Choudhury Mahesh | Officer - See Remarks | Construction - Special Trade Contractors | BUY | $15,353.70 | 18,730 | $287,574,790 | 220,768 | +9.3% |
| 2024-09-20 21:43 | 2024-09-12 | CNTM | ConnectM Technology Solutions, Inc. | Panigrahi Bhaskar | Director, Officer - See Remarks | Construction - Special Trade Contractors | BUY | $33,546.00 | 30,000 | $1,006,380,000 | 4,206,043 | +0.7% |
| 2024-09-20 23:01 | 2024-09-18 | CACC | CREDIT ACCEPTANCE CORP | Prescott General Partners LLC | 10% owner, Other | Personal Credit Institutions | BUY | $446.13 | 4,000 | $1,784,530 | 515,337 | +0.8% |
| 2024-09-20 23:20 | 2024-09-18 | KYN | Kayne Anderson Energy Infrastructure Fund, Inc. | MetLife Investment Management, LLC | 10% owner | Other | BUY | $7,174,084.23 | 15,280,000 | $109,620,006,999,256 | 280,000 | +100.0% |
| 2024-09-19 23:30 | 2024-09-19 | YHNAU | YHN Acquisition I Ltd | YHN Partners I Ltd | 10% owner | Blank Checks | BUY | $10.00 | 250,000 | $2,500,000 | 1,850,000 | +15.6% |
| 2024-09-20 01:48 | 2024-09-17 | CULP | CULP INC | English Aron R. | 10% owner | Broadwoven Fabric Mills, Cotton | BUY | $6.09 | 240,047 | $1,461,574 | 1,594,390 | +17.7% |
| 2024-09-19 17:14 | 2024-09-17 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.46 | 465,998 | $3,474,947 | 55,339,170 | +0.8% |
| 2024-09-20 04:27 | 2024-09-19 | JEF | Jefferies Financial Group Inc. | SUMITOMO MITSUI FINANCIAL GROUP, INC. | Director | Security Brokers, Dealers & Flotation Companies | BUY | $59.67 | 9,247,081 | $551,773,323 | 9,247,081 | +100.0% |
| 2024-09-19 02:15 | 2024-09-16 | N/A | N/A | New Mountain Guardian IV Income Rated Feeder II, Ltd. | 10% owner | Other | BUY | $10.00 | 3,000,000 | $30,000,000 | 18,000,000 | +20.0% |
| 2024-09-18 23:15 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | Enavate Sciences GP, LLC | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 882,353 | $15,000,001 | 3,761,359 | +30.6% |
| 2024-09-18 15:54 | 2024-09-16 | N-A | N/A | Manulife (Singapore) Pte. Ltd. | 10% owner | Other | BUY | $16.60 | 1,204,675 | $20,000,019 | 11,501,310 | +11.7% |
| 2024-09-18 19:24 | 2024-09-16 | TAKIX | N/A | PRINCIPAL LIFE INSURANCE CO | 10% owner | Other | BUY | $25.00 | 400,000 | $10,000,000 | 400,000 | +100.0% |
| 2024-09-18 19:42 | 2024-09-13 | N/A | N/A | Amwal Investments LLC | 10% owner | Other | BUY | $25.14 | 497,298 | $12,502,074 | 1,497,298 | +49.7% |
| 2024-09-18 22:10 | 2024-09-16 | N/A | N/A | Caisse de retraite d'Hydro-Quebec | 10% owner | Other | BUY | $10,000,000.00 | 1,000,000 | $10,000,000,000,000 | 6,000,000 | +20.0% |
| 2024-09-18 23:16 | 2024-09-16 | N/A | N/A | Suva | 10% owner | Other | BUY | $10.00 | 546,000 | $5,460,000 | 276,000 | +100.0% |
| 2024-09-19 01:02 | 2024-09-16 | BCAX | Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 1,833,000 | $32,994,000 | 2,652,575 | +223.7% |
| 2024-09-18 23:31 | 2024-09-16 | OMIC | N/A | TANG KEVIN | 10% owner | Other | BUY | $14.75 | 122,416 | $1,806,224 | 372,000 | +49.0% |
| 2024-09-18 23:19 | 2024-09-16 | TAKAX | N/A | SECURIAN ASSET MANAGEMENT, INC | 10% owner | Other | BUY | $25.00 | 544,000 | $13,600,000 | 144,000 | +100.0% |
| 2024-09-18 03:17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Yang Rick | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:12 | 2024-09-16 | MBX | MBX Biosciences, Inc. | New Enterprise Associates 17, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 02:48 | 2024-09-12 | TERN | Terns Pharmaceuticals, Inc. | Lu Hongbo | Director | Pharmaceutical Preparations | BUY | $10.50 | 476,190 | $4,999,995 | 476,190 | +100.0% |
| 2024-09-18 03:23 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Chang Carmen | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:05 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Aynechi Tiba | Director | Pharmaceutical Preparations | BUY | $16.00 | 750,000 | $12,000,000 | 2,136,335 | +54.1% |
| 2024-09-18 03:56 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | Fairmount Funds Management LLC | Director | Pharmaceutical Preparations | BUY | $17.00 | 300,000 | $5,100,000 | 1,892,806 | +18.8% |
| 2024-09-18 03:20 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Makhzoumi Mohamad | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:24 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Behbahani Ali | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 04:00 | 2024-09-13 | VRDN | Viridian Therapeutics, Inc.\DE | Fairmount Funds Management LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.75 | 1,600,000 | $30,000,000 | 3,445,813 | +86.7% |
| 2024-09-18 03:21 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Florence Anthony A. Jr. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-17 15:55 | 2024-09-13 | BRCC | BRC Inc. | Welling Glenn W. | Director, 10% owner | Beverages | BUY | $3.17 | 684,542 | $2,169,998 | 13,535,560 | +5.3% |
| 2024-09-18 03:18 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Walker Paul Edward | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:09 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Heron Patrick J | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 625,000 | $10,000,000 | 4,552,774 | +15.9% |
| 2024-09-18 03:11 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Frazier Life Sciences X, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 625,000 | $10,000,000 | 4,552,774 | +15.9% |
| 2024-09-18 03:28 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Mathers Edward T | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:05 | 2024-09-16 | MBX | MBX Biosciences, Inc. | GORDON CARL L | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 750,000 | $12,000,000 | 653,787 | +100.0% |
| 2024-09-18 03:26 | 2024-09-16 | MBX | MBX Biosciences, Inc. | BASKETT FOREST | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
| 2024-09-18 03:14 | 2024-09-16 | MBX | MBX Biosciences, Inc. | SANDELL SCOTT D | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 500,000 | $8,000,000 | 3,614,486 | +16.1% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.